pathways for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, announced the formation of its Clinical Advisory Board (ClAB). The ClAB, which includes internationally renowned experts in clinical trial...
digital pathology workflows: Ibex’s Prostate AI solution, integrated into Proscia’s Concentriq® enterprise pathology platform, allowed pathologists at Quest Diagnostics to be able to sign out significantly more cases per hour. The offering was...
from Strasbourg University on a technology and related know-how initially developed by Dr. Dominique Bagnard. For more information please Visit www.findtherapeutics.com
intrauterine re-adhesion risk post TCRA, and the improvement of endometrial growth. Intrauterine adhesions (IUA) are the formation of scar tissues in the endometrial cavity as a result of damages to the endometrial basal layer of the uterus, which...
new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform. The new offerings are designed to help life sciences organizations with novel customer engagement solutions including adaptive...
biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to patients, announced the United States Food and Drug Administration (FDA) has cleared an investigational new...
to be an exceptional gathering, embracing the vibrant spirit of Singapore and fostering an immersive in-person congress format. Join us as we celebrate not only the remarkable hospitality of our Singaporean colleagues but also commemorate a pivotal...
the way forward to improve the lives of people living with liver disease around the world. We have helped to transform hepatitis C from a chronic condition into one that can be cured for millions of people. For people living with hepatitis B or D,...
XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, announced that it has unified its products...
medications that help promote adherence and ease of use for patients.” Unidose (UDS) and Bidose (BDS) Technology Platforms: Aptar’s UDS and BDS technology platforms are designed to be robust, reliable and intuitive systems for easy administration...
enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.
Thomas Mitro was recruited by Spencer Trask to lead Signal12 as president and chief executive officer. Mitro is the former president and chief operating officer of Aerie Pharmaceuticals, where he grew annual sales to more than $100 million and...
to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, using Persist's AI-based formulation technology and Nivagen's manufacturing capabilities. The collaboration aims to simplify and accelerate the...
and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. For more information please visit,www.Culinary.net
T-cell Lymphoma: Cutaneous T-cell lymphoma is a type of cutaneous non-Hodgkin lymphoma (NHL) that comes in a variety of forms and is the most common type of cutaneous lymphoma. In CTCL, T-cells, a type of lymphocyte that plays a role in the immune...
the development of groundbreaking therapeutics.” Since launching the revolutionary Maestro multielectrode array (MEA) platform in 2008, Axion BioSystems has continuously expanded its line of next-generation live-cell analysis tools to meet the...
Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Canada to the commercialization of clobetasol propionate ophthalmic suspension,...
in intelligent climate and energy solutions that matter for people and our planet for generations to come. For more information, visit www.Sensitech.com
company is backed by a strong slate of investors who helped fund the company and support its vision of delivering transformative therapies to patients in need." Jade is the fourth company to launch based on assets discovered and developed by...
commitment to excellence, and flawless execution to drive the future of research and healthcare innovation. For more information, please visit: www.eximiaresearch.com.
